Beacon of Life Chiropractic highlights the professional background of Dr. Megan McClimon, one of its co-founders, who brings experience from leading chiropractic offices in the Southeast United States ...

Referral software companies are another example of businesses that are unlikely to be heavily disrupted by AI. Their products usually function as execution tools for their customers rather than ...

👉 Learn how to evaluate trigonometric functions using trigonometric identities. Trigonometric identities are equalities that involve trigonometric functions. We will focus on the cofunction ...

POWELL, OH - March 07, 2026 - PRESSADVANTAGE - Be Aligned Health offers a collection of at-home video resources from ...

Joseph Anaya, MD, and Ashkan Abbey, MD, discuss how retina specialists identify appropriate candidates for complement inhibitor therapy in geographic atrophy, set patient expectations, and monitor ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — YARTEMLEA is the first and only approved ...

Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA ® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant ...

— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — Omeros Corporation (NASDAQ: OMER) today ...

What if you could transform hours of tedious spreadsheet work into just minutes of streamlined efficiency? Simon Sez IT takes a closer look at how Excel’s most powerful functions can transform the way ...

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic ...